Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study
- PMID: 15525845
- DOI: 10.1097/01.md.0000145366.40805.f8
Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study
Abstract
Most classical manifestations of giant cell arteritis (GCA) are the result of occlusive vascular involvement. However, unlike ischemic manifestations, aortic aneurysmal disease in patients with GCA has been less well described. We assessed the incidence and predictors of aortic aneurysm and dissection in patients with biopsy-proven GCA from the Lugo region of northwestern Spain and compared the results with those in a 2003 report from Olmsted County, MN. We performed a retrospective study of biopsy-proven GCA patients diagnosed from 1981 to 2001 at the single hospital for a well-defined population of almost 250,000 people. Twenty (9.5%) of the 210 biopsy-proven GCA patients diagnosed during the study period developed aortic aneurysmal disease. Sixteen of the 20 patients had thoracic aneurysms and 6 had abdominal aneurysms. The incidence of aortic aneurysm and/or dissection in Lugo (18.9 per 1000 person years at risk) was similar to that reported in Olmsted County (18.7 per 1000 person years at risk). Hypertension (hazard ratio: 4.73) and polymyalgia rheumatica with a marked acute inflammatory response at the time of diagnosis of GCA (hazard ratio: 3.71) were the best predictors of aortic aneurysmal disease. Our present observations suggest that a severe inflammatory response associated with hypertension at the time of diagnosis of GCA may promote the development of aortic aneurysmal disease. GCA patients having these features should be monitored for the existence of aortic aneurysm and dissection.
Similar articles
-
Large vessel involvement in biopsy-proven giant cell arteritis: incidence, distribution, and predictors.Scand J Rheumatol. 2017 May;46(3):215-221. doi: 10.1080/03009742.2016.1190984. Epub 2016 Jul 6. Scand J Rheumatol. 2017. PMID: 27385090
-
Incidence of aortic aneurysm, dissection, or rupture among patients with polymyalgia rheumatica and giant cell arteritis.Semin Arthritis Rheum. 2025 Jun;72:152714. doi: 10.1016/j.semarthrit.2025.152714. Epub 2025 Mar 15. Semin Arthritis Rheum. 2025. PMID: 40127549
-
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.Ann Rheum Dis. 2001 Apr;60(4):367-71. doi: 10.1136/ard.60.4.367. Ann Rheum Dis. 2001. PMID: 11247867 Free PMC article.
-
Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.Drugs Aging. 2011 Aug 1;28(8):651-66. doi: 10.2165/11592500-000000000-00000. Drugs Aging. 2011. PMID: 21812500 Review.
-
Clinical features of polymyalgia rheumatica and giant cell arteritis.Nat Rev Rheumatol. 2012 Sep;8(9):509-21. doi: 10.1038/nrrheum.2012.97. Epub 2012 Jul 24. Nat Rev Rheumatol. 2012. PMID: 22825731 Review.
Cited by
-
Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New Zealand.Front Med (Lausanne). 2022 Nov 22;9:1057917. doi: 10.3389/fmed.2022.1057917. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36482913 Free PMC article.
-
Epidemiology of thoracic aortic dissection.Nat Rev Cardiol. 2011 Feb;8(2):103-13. doi: 10.1038/nrcardio.2010.187. Epub 2010 Dec 21. Nat Rev Cardiol. 2011. PMID: 21173794 Review.
-
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.Ann Rheum Dis. 2013 Dec;72(12):1989-94. doi: 10.1136/annrheumdis-2012-202408. Epub 2012 Dec 19. Ann Rheum Dis. 2013. PMID: 23253927 Free PMC article.
-
Design of the tocilizumab in giant cell arteritis trial.Int J Rheumatol. 2013;2013:912562. doi: 10.1155/2013/912562. Epub 2013 Apr 7. Int J Rheumatol. 2013. PMID: 23653652 Free PMC article.
-
Giant cell arteritis.Curr Pain Headache Rep. 2006 Dec;10(6):415-20. doi: 10.1007/s11916-006-0071-6. Curr Pain Headache Rep. 2006. PMID: 17087865 Review.
References
-
- Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum. 1994;37:1007-1012.
-
- Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246-249.
-
- Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, Vilaseca J, Urbano-Marquez A, Grau JM. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum. 1998;41:26-32.
-
- Cid MC, Hernandez-Rodriguez J, Esteban MJ, Cebrian M, Gho YS, Font C, Urbano-Marquez A, Grau JM, Kleinman HK. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation. 2002;106:1664-1671.
-
- Evans JM, Bowles CA, Bjornsson J, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum. 1994;37:1539-1547.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical